Boston Scientific (BSX) Q1 2026 (USD): Adj. EPS 0.80 (exp. 0.79), Revenue 5.2bln (exp. 5.17bln); Next Qtr. Adj. EPS 0.82-0.84 (exp. 0.86); Current FY EPS 3.34-3.41 (prev. guided 3.43-3.49, exp. 3.46)